west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "肖锡俊" 44 results
  • 瓣膜病心房颤动外科治疗的现状与进展

    Release date:2016-08-30 06:02 Export PDF Favorites Scan
  • 2017 STS 外科治疗心房颤动临床实践指南中文版及解读

    在不额外增加手术死亡率风险和主要并发症发生率情况下,对于二尖瓣手术同期行外科消融心房颤动(房颤)推荐二尖瓣手术同期行外科消融房颤(Ⅰ级推荐,A 级证据)。  在不额外增加手术死亡率风险和主要并发症发生率情况下,对于孤立性主动脉瓣置换手术、孤立性冠状动脉旁路移植术或主动脉瓣手术合并冠状动脉旁路移植术同期行外科消融房颤,推荐上述手术同期行外科消融房颤(Ⅰ级推荐,B 级非随机证据)。  对于有症状房颤但无结构性心脏病同时不能耐受Ⅰ/Ⅲ抗心律失常药物或(和)导管消融,行孤立的外科消融房颤是合理的(ⅡA级推荐,B 级随机证据)。  对于有症状、永久或长程房颤但无结构性心脏病,行孤立迷宫Ⅲ/Ⅳ手术相比肺静脉隔离外科消融房颤是合理的(ⅡA 级推荐,B 级非随机证据)。  对于左房扩大大于 45 mm 或中度以上的二尖瓣反流,不建议行孤立性肺静脉隔离的外科消融房颤(Ⅲ级推荐无受益,C 级专家共识)。  外科消融房颤同期行左心耳切除或隔离预防长期血栓栓塞并发症是合理的(ⅡA 级推荐,C 级有限证据)。  房颤患者行心脏手术同期外科处理左心耳预防长期血栓栓塞并发症是合理的(ⅡA 级推荐,C 级专家共识)。  处理房颤时,多学科心脏团队评估、制定治疗计划和长期随访对于优化手术治疗结果是有用和有益的(Ⅰ级推荐,C 级专家共识)。

    Release date:2017-04-01 08:56 Export PDF Favorites Scan
  • Interpretation of executive summary of the Ⅱ Brazilian guidelines for atrial fibrillation

    Release date:2017-04-24 03:51 Export PDF Favorites Scan
  • 心瓣膜置换时采用盐水冲洗射频改良迷宫手术治疗心房颤动

    目的介绍心瓣膜置换时采用盐水冲洗射频改良迷宫手术治疗心房颤动(AF)的技术要点。方法对74例心瓣膜疾病合并AF患者行心瓣膜置换时采用盐水冲洗射频改良迷宫手术治疗AF,射频能量25~30W,盐水冲洗速度180~240ml/h。首先完成右心房主要的切口和消融,在心脏停搏后进行左心房消融,继后处理心瓣膜。心脏复跳后再完成右心房剩余的消融和缝合切口。结果本组患者体外循环时间102±26rain,主动脉阻断时间58土22min,射频消融时间12±5min。住院死亡2例,其中死于机械瓣膜故障1例,多器官功能衰竭1例。术后随访70例,随访时间1.0~3.5年,随访过程中突然死亡2例。60例患者恢复窦性心律(85.7%,60/70)。结论心瓣膜疾病合并持续AF的患者在行心瓣膜置换术时,同期行盐水冲洗的射频改良迷宫手术是合理及有效的。

    Release date:2016-08-30 06:23 Export PDF Favorites Scan
  • Progress of anticoagulant therapy of the patients with mechanical prosthetic valve replacement

    The patients with mechanical prosthetic valve replacement need anticoagulant therapy for all their life. The incidence of thromboembolism and anticoagulation-related bleeding events still account for major postoperative complications after mechanical heart valve replacement. Most of the complications happen in the first half year after operation. Therefore, early anticoagulation therapy is very important. Of course, so far most guidelines focus stating their opinions on long-term anticoagulant therapy. However, there is no consensus about anticoagulant therapy in the early period of postoperation. In this review, we summarize early anticoagulant therapy of the patients with mechanical heart valve replacement through consulting domestic and abroad relevant research in recent years and give an overview of the present situations of early anticoagulant therapy.

    Release date:2017-11-01 01:56 Export PDF Favorites Scan
  • The Study in Etiology of Atrial Fibrillation

    Atrial fibrillation (AF) as a most frequent arrhythmia has a high incidence of 79% in patients with mitral valve disease. Thrombosis, embolization and serious arrhythmia can be caused by AF. There is the recrudescent tendency in using drugs to recover the sinus rhythm, surgery and radio frequency ablation can only cure a part of patients. By now the pathogenesis of AF is not known clearly. The pathogenesis of AF from virulence gene, cardiac electrophysiology, connecxins, cell ultramicrostructure and cell signaling system are reviewed in this article.

    Release date:2016-08-30 06:23 Export PDF Favorites Scan
  • The Key Role of Lysyl Oxidase in the Structural Remodeling of Atrial Fibrillation

    Release date: Export PDF Favorites Scan
  • 双瓣膜置换术后延迟性Ⅲ°房室传导阻滞一例

    Release date:2016-08-30 06:13 Export PDF Favorites Scan
  • Observation of left atrial hydrodynamic change in patients with rheumatic mitral stenosis

    Objective To investigate the correlation between the left atrial hydrodynamic change and atrial fibrillation (AF) in the patients with rheumatic mitral stenosis. Methods According to cardiac rhythm before operation, 49 patients with rheumatic mitral stenosis accompanying chronic AF were divided into two groups,group A: AF, 25 cases; group B: sinus rhythm, 24 cases. Control group : 29 healthy volunteers were examined. By using echocardiography, left atrial hydrodynamics were tested, and repeated 6-8 months after the operation. Results Left atrial stress (LAS), left atriala area (LAA) and left atrial volume(LAV) in group A after operation was much lower than before operation, LAS after operation in group B was also lower than before operation(Plt;0.01). Before operation, LAS in group A was significantly lower than that in group B, LAA and LAVwere larger. After operation, LAA and LAV in group A were significantly larger than those in group B(Plt;0.01). LAS, LAA and LAV in group A and group B before and after operation were higher than those in control group. Conclusion Left atrial hydrodynamic enviroment in patients with mitral stenosis has not reached normal even after valve replacement, LAS may be an important factor of causing AF.

    Release date:2016-08-30 06:27 Export PDF Favorites Scan
  • 抑肽酶对心瓣膜置换术患者围术期IL-6、IL-8释放的影响

    目的 了解抑肽酶对心瓣膜置换术患者围术期全身炎症应答的影响。方法 将接受心瓣膜置换术的16例患者随机分为:对照组(n=8),不用抑肽酶;治疗组(n=8),于预冲液中加入抑肽酶300万单位,分别于术前、停机、停机后1小时和术后1天抽取外周血2ml,收集血清用酶联免疫吸附测定(ELISA)双抗夹心法检测白细胞介素-6(IL-6)和白细胞介素-8(IL-8)。结果 体外循环术后患者血清IL-6和IL-8水平升高(P<0.05);术后1天仍高于术前;停机后1小时治疗组IL-6水平和停机时IL-8水平低于对照组,但差别均无显著性意义(P>0.05)。结论 尽管抑肽酶有抗炎症效应,但仅预冲液中加入抑肽酶300万单位无法有效抑制心瓣膜置换术患者围术期促炎性细胞因子IL-6和IL-8的释放。

    Release date:2016-08-30 06:33 Export PDF Favorites Scan
5 pages Previous 1 2 3 4 5 Next

Format

Content